Skip to content
MarketScale
‹ Back to IndustriesHealthcare

PROTECTING WORKERS IN BLISTERING HEAT: UAE NOW RECOMMENDS WARNING SYSTEM TO AVOID HEAT RELATED ILLNESSES

The climate in the United Arab Emirates (UAE) can be characterized by oppressive summer heat. In fact, the hottest months of July and August exceed 122oF (50oC) in average. These extreme temperatures pose a significant danger to those who work outside, such as in construction, a booming industry in UAE. A study commissioned by the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

The climate in the United Arab Emirates (UAE) can be characterized by oppressive summer heat. In fact, the hottest months of July and August exceed 122oF (50oC) in average. These extreme temperatures pose a significant danger to those who work outside, such as in construction, a booming industry in UAE. A study commissioned by the UAE Ministry of Climate Change and Environment discovered that heat stress is the most likely health issue in these conditions. Heat stress can lead to more serious medical problems including heat exhaustion and heat stroke, which can be fatal. From their findings, the Ministry concluded that warning systems should be put in place to alert outdoor workers to dangerous rises in temperature. These systems could help reduce the number of workers negatively affected by intense heat, thus protecting the workforce and the bottom line alike.

The Dangers of Workplace Heat

Breezer Mobile Cooling understands that safety is a top priority for employers. Heat in the workplace is not only detrimental to worker health and safety, but also hinders productivity while increasing the risk for workplace accidents.

As temperatures rise in the workplace, there are adverse physiological effects on the body. Cognitive ability and productivity decrease as heat increases. This not only lessens the output of each worker, but also reduces physical and decision-making abilities, making individuals more prone to mistakes. A perilous domino effect, heat related illness not only puts the affected worker at risk, but opens surrounding employees and processes to serious danger as well!

Heat stress has been documented at heat indexes as low as 84oF. With summertime temperatures in the UAE easily exceeding 122oF, the risk of heat illness increases dramatically. Furthermore, the higher the temperature, the more rapid the progression of other heat-related medical conditions. This means keeping workers cool is even more critical!

Breezer Mobile Cooling Solutions

It’s no surprise that the UAE Ministry of Climate Change and Environment recognizes this. It now mandates that it is important to both identify the presence of hot working conditions and take the necessary precautions to combat their effect as well. Recommended are systematic rest breaks in shaded areas, maintaining proper hydration, and the use of cooling towels.

A firm believer that everyone deserves to be cool, Breezer Mobile Cooling, a leader in workforce cooling solutions, has developed portable, eco-friendly cooling equipment that is exceedingly effective in even the harshest environments. Our local UAE representation is here to help. To contact our Dubai office, click here.

To learn more about our flagship products Power Breezer and O2 click here.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512